Colonoscopy for a family history of colorectal cancdr: are we screenin "the worried well"? by Hunt, AK et al.
DDF 2012 - Abstract Submission
Colorectal
DDF12-1295
COLONOSCOPY FOR A FAMILY HISTORY OF COLORECTAL CANCER: ARE WE SCREENING 'THE WORRIED
WELL'?
A. K. Hunt 1,*, S. Qiu 1, Z. Mohamed 1, I. Beveridge 1, C. E. Collins 1, J. Mawdsley 1, K. Sundaram 1, K. J. Monahan 1
1Family History of Bowel Cancer Clinic, West Middlesex University Hospital, London, United Kingdom
Is this abstract original?: Yes
Will this abstract be published/presented prior to June 2012?: Yes
Abstract Presented at/ Published in: UEGW 2011, abstract published in GUT supplement
Preferred Presentation Type: Oral Or Poster Presentation
My abstract is submitted for the following society:: BSG
Introduction: The British Society of Gastroenterology (BSG) updated guidelines for colonoscopic screening of people
with family history (FH) of colorectal cancer (CRC) in 2010. In the UK, most patients anxious about their FH of CRC are
referred by primary care doctors to non-specialist hospitals. Previous studies indicate guideline adherence is poor with
significant clinical, medico-legal, and resource implications.
Methods: Our study analysed adherence to the 2010 BSG guidelines in a district general hospital (catchment population
of 300,000). Observational data was collected from all colonoscopies in which FH was the primary indication over a 16
month period from guideline publication up to April 2011 at our centre.
Results: Of the 91 cases found (mean age 49.1 years, range 24.7-73.2), there were 11 high, 24 high moderate and 20
low moderate risk cases identified. 36 were low risk and did not fulfill criteria for initial colonoscopic screening. The 55
within guideline were screened on average 4.0 years early (p < 0.0002; paired T test; 0-24.2 years early), with 18 cases
screened early. 17 of the 91 cases were offered unnecessary follow-up colonoscopies. Yield for polyps and CRC was
significantly lower in screened individuals (16/91 (18%)) compared to patients offered colonoscopies for other indications
during the same period (246/838 (25%); p = 0.018; Χ2 test). Referrers recorded 'reassurance' in 29 cases as a factor for
screening.
 Risk Life time risk of
CRC death
n (%)  Cases screened
early
Inappropriate
follow up
Polyp/CRC cases
found
Appropriate for screening
High (i.e. known
familial
syndrome)
1 in 2-5 11 (12%)  0 0 2
High Moderate ~1 in 6-10 24 (26%) 6 8 5
Low Moderate ~1 in 12 20 (22%) 12 3 3
Inappropriate for screening
Low >1:12 36(40%) N/A 6 6
Total  91 18/55 (33%) 17/91(19%) 16/91(18%)
Conclusion: The BSG guidelines are based on robust evidence. Despite this, many patients (40%) undergoing
screening in our centre do not meet guideline criteria. Some (33%) were screened too early, and others (19%) had
unnecessary follow up. Therefore, some patients are exposed to the risk of colonoscopy decades younger than
recommended without justifiable benefits. This is reflected in similar data from other centres. Non adherence to guideline
occurs at multiple levels from referral and beyond. Clinicians often feel compelled to offer screening against guidelines for
the reassurance of anxious patients. Our study identifies multiple opportunities where intervention could result in better
adherence to guidelines; interventions such as the development of family cancer clinics outside clinical genetics centres
to improve management of these patients.
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